TWD 684.0
(1.94%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 14.2 Billion TWD | 35.31% |
2022 | 10.49 Billion TWD | 114.18% |
2021 | 4.89 Billion TWD | 172.28% |
2020 | 1.79 Billion TWD | 17.68% |
2019 | 1.52 Billion TWD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 5.02 Billion TWD | 75.93% |
2024 Q1 | 2.85 Billion TWD | -10.86% |
2023 Q2 | 3.13 Billion TWD | -34.35% |
2023 Q4 | 3.2 Billion TWD | 4.23% |
2023 FY | 14.2 Billion TWD | 35.31% |
2023 Q1 | 4.78 Billion TWD | -9.77% |
2023 Q3 | 3.07 Billion TWD | -2.01% |
2022 Q3 | 2.72 Billion TWD | 0.0% |
2022 FY | 10.49 Billion TWD | 114.18% |
2022 Q4 | 5.29 Billion TWD | 94.5% |
2021 FY | 4.89 Billion TWD | 172.28% |
2020 FY | 1.79 Billion TWD | 17.68% |
2019 FY | 1.52 Billion TWD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Grape King Bio Ltd | 10.63 Billion TWD | -33.547% |
Standard Chem & Pharm CO., LTD. | 6.23 Billion TWD | -127.574% |
Maywufa Company Ltd. | 1.3 Billion TWD | -991.707% |
ScinoPharm Taiwan, Ltd. | 3.18 Billion TWD | -345.69% |
Lotus Pharmaceutical Co., Ltd. | 16.95 Billion TWD | 16.263% |
LIWANLI Innovation Co., Ltd. | 38.88 Million TWD | -36416.234% |
YungShin Global Holding Corporation | 7.02 Billion TWD | -102.052% |
PhytoHealth Corporation | 162.48 Million TWD | -8639.095% |
SCI Pharmtech, Inc. | 1.2 Billion TWD | -1079.252% |
Formosa Laboratories, Inc. | 4.36 Billion TWD | -225.656% |
PharmaEssentia Corporation | 5.1 Billion TWD | -178.126% |